These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 23328511

  • 61. Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study.
    Miroslawska A, Solbu M, Skjølsvik E, Toft I, Steigen TK.
    J Hum Hypertens; 2016 Mar; 30(3):153-7. PubMed ID: 26134621
    [Abstract] [Full Text] [Related]

  • 62. Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk.
    Zaldivia MT, Rivera J, Hering D, Marusic P, Sata Y, Lim B, Eikelis N, Lee R, Lambert GW, Esler MD, Htun NM, Duval J, Hammond L, Eisenhardt SU, Flierl U, Schlaich MP, Peter K.
    Hypertension; 2017 Feb; 69(2):323-331. PubMed ID: 27956575
    [Abstract] [Full Text] [Related]

  • 63. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F, Ewen S, Ukena C, Linz D, Sobotka PA, Cremers B, Böhm M.
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [Abstract] [Full Text] [Related]

  • 64. [Endovascular radiofrequency denervation of renal arteries as an innovation method of treatment of refractory arterial hypertension. First experience in Russia].
    Danilov NM, Matchin IuG, Chazova IE.
    Angiol Sosud Khir; 2012 May; 18(1):51-4. PubMed ID: 22836328
    [Abstract] [Full Text] [Related]

  • 65. [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].
    Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Krämer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC, Arbeitsgemeinschaft Herz und Niere der Deutschen Gesellschaftfür Kardiologie – Herz- und Kreislaufforschunge V und der Deutschen Gesellschaft für Nephrologiee  V sowie der Deutschen Hochdruckliga e V DHL® – DeutscheGesellschaft für Hypertonie und Prävention.
    Dtsch Med Wochenschr; 2011 Nov; 136(47):2418. PubMed ID: 22048949
    [Abstract] [Full Text] [Related]

  • 66. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M.
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Denervation of the renal arteries in metabolic syndrome: the DREAMS-study.
    Verloop WL, Spiering W, Vink EE, Beeftink MM, Blankestijn PJ, Doevendans PA, Voskuil M.
    Hypertension; 2015 Apr; 65(4):751-7. PubMed ID: 25646297
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. Catheter-based renal sympathetic denervation improves central hemodynamics and arterial stiffness: a pilot study.
    Mortensen K, Franzen K, Himmel F, Bode F, Schunkert H, Weil J, Reppel M.
    J Clin Hypertens (Greenwich); 2012 Dec; 14(12):861-70. PubMed ID: 23205753
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Renal sympathetic denervation and systemic hypertension.
    Doumas M, Faselis C, Papademetriou V.
    Am J Cardiol; 2010 Feb 15; 105(4):570-6. PubMed ID: 20152255
    [Abstract] [Full Text] [Related]

  • 74. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
    Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL.
    Eur Heart J; 2015 Jan 21; 36(4):219-27. PubMed ID: 25400162
    [Abstract] [Full Text] [Related]

  • 75. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
    Rosa J, Widimský P, Toušek P, Petrák O, Čurila K, Waldauf P, Bednář F, Zelinka T, Holaj R, Štrauch B, Šomlóová Z, Táborský M, Václavík J, Kociánová E, Branny M, Nykl I, Jiravský O, Widimský J.
    Hypertension; 2015 Feb 21; 65(2):407-13. PubMed ID: 25421981
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Renal Sympathetic Denervation by CT-Guided Ethanol Injection: A Phase II Pilot Trial of a Novel Technique.
    Ricke J, Seidensticker M, Becker S, Schiefer J, Adamchic I, Lohfink K, Kandulski M, Heller A, Mertens PR.
    Cardiovasc Intervent Radiol; 2016 Feb 21; 39(2):251-60. PubMed ID: 26634740
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.
    Feyz L, Theuns DA, Bhagwandien R, Strachinaru M, Kardys I, Van Mieghem NM, Daemen J.
    Clin Res Cardiol; 2019 Jun 21; 108(6):634-642. PubMed ID: 30413869
    [Abstract] [Full Text] [Related]

  • 80. Long-term follow-up after radio-frequency catheter-based denervation in patients with resistant hypertension.
    Skowerski M, Roleder T, Bańska-Kisiel K, Pysz P, Ochała A, Wojakowski W, Gąsior Z.
    Int J Cardiol; 2016 Jul 15; 215():472-5. PubMed ID: 27131767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.